Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Inflammation × Dermatologic × Clear all

Status

Withdrawn 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Breast 9 Gastrointestinal 6 Thoracic 4 Lymphoid 3 Other 2 Plasma cell 1 Other hematologic neoplasm 1 Gynecologic 1 Genitourinary 1 Dermatologic 1 Classical hematology 1 CNS 1

Conditions

Melanoma 387 Skin Neoplasms 91 Carcinoma, Non-Small-Cell Lung 76 Neoplasms 55 Breast Neoplasms 53 Colorectal Neoplasms 52 Lung Neoplasms 49 Lymphoma, T-Cell, Cutaneous 44 Squamous Cell Carcinoma of Head and Neck 43 Ovarian Neoplasms 43 Neoplasm Metastasis 43 Carcinoma, Renal Cell 43 Uveal Melanoma 40 Carcinoma, Basal Cell 38 Pancreatic Neoplasms 37 Sarcoma 36 Head and Neck Neoplasms 33 Uterine Cervical Neoplasms 32 Stomach Neoplasms 31 Prostatic Neoplasms 30 Carcinoma, Hepatocellular 30 Urinary Bladder Neoplasms 29 Endometrial Neoplasms 29 Carcinoma, Merkel Cell 29 Kidney Neoplasms 26 Lymphoma 21 Esophageal Neoplasms 21 Carcinoma, Squamous Cell 21 Triple Negative Breast Neoplasms 20 Mycosis Fungoides 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07138222 2026-01-28

IMPACT

Peter MacCallum Cancer Centre, Australia

Inflammation, Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡